ArticlePloS one2026
Uncovering overlooked bacterial infections in gene X-pert MTB/RIF negative sputum samples of adult patients with presumptive tuberculosis in Harar, Eastern Ethiopia.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLower respiratory tract infections are among the diseases that pose an existential threat to global public health. Clinical presentations of various bacterial lower respiratory infections and presumptive pulmonary tuberculosis are often overlap, hindering prompt patient care and correct diagnosis. In developing countries like Ethiopia, the management of presumptive tuberculosis cases that test negative for Gene Xpert is often empirical. Consequently, it is imperative to address potential overlooked bacterial infections in cases that are negative for tuberculosis.
objectiveThis study aimed to determine the prevalence of pathogenic bacteria, antimicrobial susceptibility patterns, and associated factors of lower respiratory tract infection among Gene Xpert-negative presumptive tuberculosis adult patients at Hiwot Fana Comprehensive Specialized Hospital, eastern Ethiopia.
methodA hospital-based cross-sectional study was conducted among 371 study participants from January 01 to April 30, 2024. Socio-demographic and health related data were collected using structured questionnaire. Gene Xpert MTB/RIF was used for initial tuberculosis screening, and sputum culture was used to isolate bacterial pathogens. Bacterial isolates were identified based on gram staining, colony characteristics, and biochemical reactions. Antimicrobial susceptibility test was done using Kirby-Bauer disc diffusion method. Methicillin resistance S. aureus was confirmed using cefoxitin (30 µg). Logistic regression analysis was used to assess the association between outcome and predictor variables.
resultsThe overall prevalence of pathogenic bacterial lower respiratory tract infection was 34.0% (95% CI; 29.2, 38.8). Gram-negative bacteria accounted for 66.7%. S. aureus (19.0%) was the predominant isolate followed by K. pneumoniae (14.3%). The proportion of multi-drug resistant bacteria and methicillin-resistance S. aureus was 39.7% and 16.7% respectively. Primary education (AOR = 4.01; 95% CI = 1.62, 9.92), history of antibiotic usage (AOR = 1.87; 95% CI = 1.13, 3.08) and crowded living condition (AOR = 5.11; 95% CI = 3.03, 8.61) were factors associated with pathogenic bacterial lower respiratory tract infections.
conclusionThis study revealed that patients with presumptive tuberculosis who tested negative on Gene Xpert- were predominantly infected with gram negative pathogenic bacteria. Therefore, it's important to prioritize sputum culture and antibiotic susceptibility testing. This study underscore the need to avoid the misuse of antibiotics and crowded living conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.